Brief: Heidelberg Pharma H1 Net Loss Widens To EUR 4.7 Mln

Heidelberg Pharma AG

12/07/2018 06:15

July 12 (Reuters) - Heidelberg Pharma AG  WL6G.DE :
    * H1 SALES REVENUE AND INCOME TOTALING EUR 2.2 MILLION, THUS DOUBLING PRIOR-YEAR FIGURE OF
EUR 1.1
MILLION
    * H1 OPERATING EXPENSES, INCLUDING DEPRECIATION, AMORTIZATION AND IMPAIRMENT, AMOUNTED TO
EUR 6.9
MILLION
    * H1 NET LOSS ROSE BY 9% TO EUR 4.7 MILLION FROM EUR 4.3 MILLION FOR SAME PERIOD IN 2017
    * TOTAL ASSETS AS OF END OF REPORTING PERIOD AMOUNTED TO EUR 36.9 MILLION
    * CONFIRMS ITS GUIDANCE FOR CURRENT FISCAL YEAR PROVIDED AT END OF MARCH 2018

Source text for Eikon:  ID:nEQ4WZBHa 
Further company coverage:  WL6G.DE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))